Business Context and Reporting Period
Kforce Inc. filed this Form 8-K on March 30, 2012, reporting the completion of a significant asset disposition. The transaction involves the sale of Kforce Clinical Research, Inc. (KCR), a segment engaged in functional outsourcing solutions and staffing for clinical research.
Key Financial Metrics
- Transaction Value: Total cash purchase price of $50.0 million.
- Adjustments: The price is subject to a post-closing working capital adjustment.
- Accounting Treatment: KCR will be accounted for as a discontinued operation for all periods presented beginning with the first quarter of fiscal 2012.
- Pro Forma Data: Unaudited pro forma condensed consolidated financial statements are provided in Exhibit 99.1, reflecting the elimination of KCR's assets, liabilities, and results of operations.
Material Changes
The primary material change is the divestiture of the KCR segment. The sale closed on March 30, 2012, effective as of March 31, 2012. This transaction removes the clinical research business from Kforce Inc.'s consolidated results. The filing notes that other than the agreement and transitional services, there are no material relationships between Kforce and the purchaser, inVentiv Health, Inc.
Outlook, Risks, and Contingencies
- Transitional Services: Kforce has agreed to provide post-closing transitional services for a period not to exceed 18 months.
- Pro Forma Limitations: The pro forma financial statements are for illustrative purposes only and are not necessarily indicative of future operating results or financial position.
- Working Capital: The final consideration may vary based on the post-closing working capital adjustment.
Investor Verification Checklist
- Review Exhibit 99.1 for the unaudited pro forma condensed consolidated financial statements to understand the impact of the divestiture on historical results.
- Monitor the finalization of the post-closing working capital adjustment to determine the exact cash proceeds received.
- Verify the scope and duration of the transitional services agreement to assess any ongoing operational obligations or revenue streams.
- Confirm the classification of KCR as a discontinued operation in future quarterly and annual reports.